Is ASMB or ASND more undervalued in 2026?

CirclFi compares Assembly Biosciences, Inc. (ASMB) and Ascendis Pharma A/S (ASND) using 13 institutional-grade valuation models. ASMB has a Quality of Company score of 6.1/10 while ASND scores 5.9/10.

Which is a better buy — ASMB or ASND?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ASMB and ASND valuations compare?

ASMB at $27.73 and ASND at $237.47 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ASMB vs ASND Valuation Comparison 2026 — Intrinsic Value Analysis

ASMB

Biotechnology

Assembly Biosciences, Inc.

Quality

6.1

out of 10

Value Trap

SAFE

Price

$27.73

Last close

Models

9/13

Active

ASND

Biotechnology

Ascendis Pharma A/S

Quality

5.9

out of 10

Value Trap

SAFE

Price

$237.47

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	ASMB Fair Value	ASMB Upside	ASND Fair Value	ASND Upside
Bayesian DCF	Intrinsic	$6.31	-77.3%	$69.36	-70.8%
Earnings Power Value	Intrinsic	—	—	$7.22	-96.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$5.49	-80.2%	$8.95	-96.4%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ASMB vs ASND — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ASMB vs ASND — Which Stock Is More Undervalued?

ASMB scores higher with a 6.1/10 quality rating vs ASND's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Assembly Biosciences, Inc. (ASMB) and Ascendis Pharma A/S (ASND) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ASMB currently trades at $27.73 with a QOC of 6.1/10, while ASND trades at $237.47 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).